Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Mounjaro Thailand — Tirzepatide, Doctor-Led in Bangkok from ฿12,000
Recommended by Doctor
GLP-1 / GIP Program

Mounjaro Thailand — Tirzepatide, Doctor-Led in Bangkok from ฿12,000

Healthi Life · Ekkamai 10, Bangkok

Diet and exercise stop working long before the weight does. Tirzepatide acts on two incretin receptors, GIP and GLP-1, and changes what the body does with food: in the SURMOUNT-1 trial, mean body-weight change was −16.0% at 5 mg and −21.4% at 10 mg over 72 weeks, against −2.4% on placebo. At Healthi Life Ekkamai the program starts at ฿12,000 and is prescribed only after a medical intake, contraindication review and baseline labs.

Starting from฿12,000

2.5 mg vial, includes consultation — indicative, confirmed at physician consultation

Book ConsultationWhatsAppCall +66 91 999 1744
Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

What You Get

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Injection training and monthly clinical follow-up
Why Choose This Treatment

How Tirzepatide Works — Mounjaro Thailand Programmes

Dual GIP/GLP-1 Action

Tirzepatide activates two incretin receptors to support glycemic control and appetite regulation.

Physician-Supervised

Every program is initiated and titrated by a licensed physician at Healthi Life Ekkamai.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

Personal and family history screening before initiation, including MTC and MEN-2 exclusion.

Subcutaneous Injection

Weekly subcutaneous administration with in-clinic injection training and adherence support.

Longevity Integration

Coordinated with metabolic, hormone and biomarker programs for long-term outcomes.

Is This Right For You?

Ideal For

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Type 2 diabetes inadequately controlled on first-line therapy
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review

Not Recommended For

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
Your Journey

Our 4-Step Mounjaro Program

1

Medical Intake

Full history, medication review, and contraindication screening with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before the first dose.

3

Titration

Progressive dose escalation 2.5 → 5 → 7.5 → 10 mg based on tolerability and response.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

Medical Excellence

Why Trust Healthi Life

Physician-led protocols, international certifications, and a commitment to guest safety in Bangkok.

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards

Mounjaro vs Ozempic vs Wegovy

A factual comparison of mechanism and administration. Individual response varies; all three require physician supervision.

FeatureMounjaroOzempicWegovy
MoleculeTirzepatideSemaglutideSemaglutide
Receptor targetsGIP + GLP-1 (dual)GLP-1 onlyGLP-1 only
Injection frequencyOnce weeklyOnce weeklyOnce weekly
Approved indicationType 2 diabetes + chronic weight managementType 2 diabetesChronic weight management
ManufacturerEli LillyNovo NordiskNovo Nordisk

Regulatory status

Tirzepatide is a prescription-only medicine. Under the Thai Drug Act (พ.ร.บ.ยา) a prescription medicine may not be advertised to the general public, and it may only be dispensed after a physician has assessed the individual — it cannot be bought over the counter, online, or from a non-medical seller. Registration status of a medicinal product in Thailand can be checked with the Thai Food and Drug Administration (อย.). It is not appropriate during pregnancy, when planning pregnancy or breastfeeding, with a personal or family history of medullary thyroid carcinoma or MEN-2, or with a history of pancreatitis. This page describes a supervised medical protocol; it is information, not an offer of treatment, and every decision is made with a physician.

Packages

Choose Your Program

Mounjaro 2.5 mg

฿12,000

  • Starter / titration dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
Select Package
RECOMMENDED

Mounjaro 5 mg

฿15,000

  • Maintenance entry dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
Select Package

Mounjaro 7.5 mg

฿18,000

  • Up-titration dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
Select Package

Mounjaro 10 mg

฿20,500

  • Higher maintenance dose
  • 1 vial
  • Physician consultation
  • Injection training & biomarker review
Select Package
FAQ

Frequently Asked Questions

At Healthi Life Ekkamai, Mounjaro (Tirzepatide) is prescribed for physician-supervised weight management and type 2 diabetes care. It is initiated only after medical intake, contraindication review and baseline biomarker assessment.

Pricing at Healthi Life is per vial: 2.5 mg ฿12,000, 5 mg ฿15,000, 7.5 mg ฿18,000, 10 mg ฿20,500. Each price includes one vial, physician consultation, injection training and biomarker review.

In SURMOUNT-1, a 72-week randomised placebo-controlled trial of 2,539 adults, mean body-weight change was −16.0% at 5 mg and −21.4% at 10 mg, against −2.4% on placebo. Those are the two doses used in the Healthi Life program. Individual response varies and is reviewed by the physician at every monthly follow-up.

The dose is escalated every four weeks — 2.5 → 5 → 7.5 → 10 mg — so the first month is a titration month, set by tolerability rather than by result. SURMOUNT-1 measured its full result at 72 weeks. At Healthi Life, progress and biomarkers are reviewed monthly and the dose is adjusted to what you tolerate.

Yes. Mounjaro is the Eli Lilly brand name for Tirzepatide, a dual GIP and GLP-1 receptor agonist. The FDA approved Tirzepatide for type 2 diabetes in 2022 and for chronic weight management in 2023.

This is a prescription medicine and must be initiated by a licensed physician. At Healthi Life Bangkok, prescription is preceded by an in-person consultation covering medical history, medication review, contraindication screening and baseline laboratory testing. There is no over-the-counter, online or walk-in supply.

Most guests follow a 3 to 12 month physician-supervised program, with monthly follow-up. Duration is individualized based on clinical goals, tolerability, biomarker trends and the broader longevity plan.

The most reported effects in clinical trials (SURPASS, SURMOUNT) are nausea, diarrhea, decreased appetite, vomiting and constipation, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease; report symptoms early.

Yes, under physician supervision. Mounjaro is frequently integrated with biomarker tracking, hormone optimization, peptide therapy and lifestyle medicine at Healthi Life. Combinations are reviewed for interactions at every monthly follow-up.

The FDA has approved Tirzepatide for chronic weight management in adults with obesity or overweight plus a comorbidity. At Healthi Life, eligibility, contraindications and risk-benefit are reviewed individually before any non-diabetic prescription.

Mounjaro is a prescription medicine in Thailand. At Healthi Life Ekkamai, access begins with a physician consultation covering medical history, contraindication screening and baseline laboratory testing. Once eligibility is confirmed, the physician issues a prescription and provides injection training with monthly follow-up.

Mounjaro (Tirzepatide) activates both GIP and GLP-1 receptors. Ozempic (Semaglutide) activates GLP-1 receptors only. Both are once-weekly injections manufactured by different companies (Eli Lilly vs Novo Nordisk). Mounjaro is approved for type 2 diabetes and chronic weight management; Ozempic is approved for type 2 diabetes. A physician determines which molecule aligns with the individual's metabolic profile and clinical goals.

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

This page is for general information and does not constitute medical advice, diagnosis, or treatment. Results vary between individuals. ⁨Mounjaro — tirzepatide⁩ is a prescription medicine, dispensed and administered only after assessment by a licensed physician. This page is medical information, not an advertisement or an offer of treatment. Always consult a qualified physician about your condition. See our full medical disclaimer.

Book a Mounjaro Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and a personalized titration plan.

Location

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

Hours

Mon-Sat: 11:00 AM – 7:00 PM

Response time: Under 2 hours

Book ConsultationWhatsApp Us+66 91 999 1744

Related Services

Explore other treatments that complement your wellness journey

Medical Weight Loss Hub

Compare Mounjaro · Wegovy · Retatrutide

Learn more

Recovery & Performance

All recovery & performance treatments

Learn more

Retatrutide Bangkok

Investigational triple agonist

Learn more

Wegovy Bangkok

Semaglutide GLP-1 program

Learn more

Ozempic Bangkok

Semaglutide (Ozempic) GLP-1 care

Learn more

Peptide Therapy

Physician-led peptide programs

Learn more